Coave Therapeutics is a clinical-stage biotechnology company focused on developing life-changing gene therapies for CNS and eye diseases using its proprietary ALIGATER platform, which enables targeted delivery and enhanced gene transduction
Coave Therapeutics is a clinical-stage biotechnology company focused on developing life-changing gene therapies for CNS and eye diseases using its proprietary ALIGATER platform, which enables targeted delivery and enhanced gene transduction.
The top three firms on F4's Biotech & Life Sciences investor list.